
Bormioli Pharma boosts revenues and earnings
Gerresheimer recorded a jump in revenues and earnings due to the first-time consolidation of Bormioli Pharma, which was acquired in 2024. Revenues in the first quarter of 2025 rose by 11.6% to €520.1 million (Q1 2024: €466.1 million), while adjusted EBITDA …